Namiki Izumi

17PUBLICATIONS
61CO-AUTHORS
Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Chemical and thermal processes in energy and combustionRespiratory diseasesMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.

Grace Lai-Hung Wong, Edward Gane, Calvin Q Pan

|Mar 07, 2025
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-concept study.

Tomoko Aoki, Masatoshi Kudo, Naoshi Nishida

|Oct 03, 2023
Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.

Hidekatsu Kuroda, Takuma Oguri, Naohisa Kamiyama

|Jan 12, 2023
Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis.

Daniel Q Huang, Nobuharu Tamaki, Hyung Woong Lee

|May 19, 2022
Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease.

Kento Inada, Nobuharu Tamaki, Masayuki Kurosaki

|Mar 10, 2022
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma.

Shun Kaneko, Masayuki Kurosaki, Kaoru Tsuchiya

Pageof 3

Frequent Collaborators

7 joint publications

Shun Kaneko

6 joint publications

Nobuharu Tamaki

5 joint publications

Yutaka Yasui

4 joint publications

Masayuki Kurosaki